Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Gender Differences in Patients with Atrial Fibrillation Undergoing Electrical Cardioversion.

Alegret JM, Viñolas X, Martínez-Rubio A, Pedrote A, Beiras X, García-Sacristán JF, Crespo-Mancebo F, Ruiz-Mateas F.

J Womens Health (Larchmt). 2015 Jun;24(6):466-70. doi: 10.1089/jwh.2014.5014.

PMID:
25978301
2.

Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.

Boriani G, Diemberger I, Biffi M, Domenichini G, Martignani C, Valzania C, Branzi A.

Int J Clin Pract. 2007 May;61(5):748-56.

PMID:
17493088
3.

Sex-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Observational Research Programme Pilot survey on Atrial Fibrillation.

Lip GY, Laroche C, Boriani G, Cimaglia P, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Popescu MI, Tica O, Hellum CF, Mortensen B, Tavazzi L, Maggioni AP.

Europace. 2015 Jan;17(1):24-31. doi: 10.1093/europace/euu155.

4.

Overtreatment and undertreatment with anticoagulation in relation to cardioversion of atrial fibrillation (the RHYTHM-AF study).

Lip GY, Gitt AK, Le Heuzey JY, Bash LD, Morabito CJ, Bernhardt AA, Sisk CM, Chazelle F, Crijns HJ; RHYTHM-AF Scientific Committee..

Am J Cardiol. 2014 Feb 1;113(3):480-4. doi: 10.1016/j.amjcard.2013.10.036.

PMID:
24332698
5.

Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.

Loricchio ML, Cianfrocca C, Pasceri V, Bianconi L, Auriti A, Calo L, Lamberti F, Castro A, Pandozi C, Palamara A, Santini M.

Am J Cardiol. 2007 May 15;99(10):1421-4.

PMID:
17493472
6.

[Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].

Larsen MT, Lyngborg K, Pedersen F, Corell P.

Ugeskr Laeger. 2005 Sep 5;167(36):3408-12. Danish.

PMID:
16159494
7.

Atrial natriuretic peptide before and after cardioversion of persistent atrial fibrillation.

Wozakowska-Kapłon B, Opolski G, Janion M.

Kardiol Pol. 2003 Apr;58(4):255-63.

PMID:
14517556
8.

[Clinical characteristics of patients with persistent atrial fibrillation referred for cardioversion: Spanish Cardioversion Registry (REVERSE)].

Alegret JM, Viñolas X, Sagristá J, Hernández-Madrid A, Berruezo A, Moya A, Martínez Sande JL, Pastor A; nombre de los investigadores del Estudio REVERSE..

Rev Esp Cardiol. 2008 Jun;61(6):630-4. Spanish.

9.

Predictors of left atrial appendage stunning after electrical cardioversion of non-valvular atrial fibrillation.

Yang S, Huang C, Hu X, Jin L, Li F, Peng S.

Chin Med J (Engl). 2003 Oct;116(10):1445-50.

PMID:
14570597
10.

Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland.

Kiliszek M, Opolski G, Włodarczyk P, Dąbrowski R, Ponikowski P.

Cardiol J. 2014;21(5):484-91. doi: 10.5603/CJ.a2014.0018.

PMID:
24526513
11.

Trends in the use of electrical cardioversion for atrial fibrillation: influence of major trials and guidelines on clinical practice.

Alegret JM, Viñolas X, Romero-Menor C, Pons S, Villuendas R, Calvo N, Pérez-Rodon J, Sabaté X; REVERCAT study investigators..

BMC Cardiovasc Disord. 2012 Jun 18;12:42. doi: 10.1186/1471-2261-12-42.

12.
13.

Gender-related differences in presentation, treatment, and outcome of patients with atrial fibrillation in Europe: a report from the Euro Heart Survey on Atrial Fibrillation.

Dagres N, Nieuwlaat R, Vardas PE, Andresen D, Lévy S, Cobbe S, Kremastinos DT, Breithardt G, Cokkinos DV, Crijns HJ.

J Am Coll Cardiol. 2007 Feb 6;49(5):572-7.

14.
15.

Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.

Naegeli B, Straumann E, Bertel O.

Int J Cardiol. 2005 Mar 18;99(2):283-7.

PMID:
15749188
16.

Low stroke risk after elective cardioversion of atrial fibrillation: an analysis of the Flec-SL trial.

Apostolakis S, Haeusler KG, Oeff M, Treszl A, Andresen D, Borggrefe M, Lip GY, Meinertz T, Parade U, Samol A, Steinbeck G, Wegscheider K, Breithardt G, Kirchhof P.

Int J Cardiol. 2013 Oct 9;168(4):3977-81. doi: 10.1016/j.ijcard.2013.06.090.

PMID:
23871349
17.

CHA2DS2-VASc in the prediction of early atrial fibrillation relapses after electrical or pharmacological cardioversion.

Falsetti L, Viticchi G, Tarquinio N, Silvestrini M, Capeci W, Balloni A, Catozzo V, Gentile A, Pellegrini F.

J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):636-41. doi: 10.2459/JCM.0000000000000139.

PMID:
24978663
18.

The effect of patient sex on recurrence of atrial fibrillation following successful direct current cardioversion.

Gurevitz OT, Varadachari CJ, Ammash NM, Malouf JF, Rosales AG, Herges RM, Bruce CJ, Somers VK, Hammill SC, Gersh BJ, Friedman PA.

Am Heart J. 2006 Jul;152(1):155.e9-13.

PMID:
16824847
19.

Efficacy of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation at 6 months: a randomized controlled trial.

Klein AL, Grimm RA, Jasper SE, Murray RD, Apperson-Hansen C, Lieber EA, Black IW, Davidoff R, Erbel R, Halperin JL, Orsinelli DA, Porter TR, Stoddard MF; ACUTE Steering and Publications Committee for the ACUTE Investigators..

Am Heart J. 2006 Feb;151(2):380-9.

PMID:
16442904
20.

Maintenance of sinus rhythm after electrical cardioversion for recurrent atrial fibrillation following mitral valve surgery with or without associated radiofrequency ablation.

van Breugel HN, Gelsomino S, de Vos CB, Accord RE, Tieleman RG, Lucà F, Rostagno C, Renzulli A, Parise O, Lorusso R, Crijns HJ, Maessen JG.

Int J Cardiol. 2014 Aug 1;175(2):290-6. doi: 10.1016/j.ijcard.2014.05.010.

PMID:
24882697
Items per page

Supplemental Content

Support Center